Genomic Valley Biotech Ltd vs Swadha Nature Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 12, 2026

Key Highlights

The Latest Trading Price of Genomic Valley Biotech Ltd is ₹ 25.13 as of 12 Mar 15:30 . The P/E Ratio of Genomic Valley Biotech Ltd changed from 694.2 on March 2024 to 50.1 on March 2025 . This represents a CAGR of -73.14% over 2 yearsThe P/E Ratio of Swadha Nature Ltd changed from 180 on March 2024 to 0 on March 2025 . This represents a CAGR of -100.00% over 2 years The Market Cap of Genomic Valley Biotech Ltd changed from ₹ 10.6 crore on March 2024 to ₹ 17.9 crore on March 2025 . This represents a CAGR of 29.95% over 2 yearsThe Market Cap of Swadha Nature Ltd changed from ₹ 2.95 crore on March 2024 to ₹ 4.8 crore on March 2025 . This represents a CAGR of 27.56% over 2 years The revenue of Genomic Valley Biotech Ltd for the Dec '25 is ₹ 0.05 crore as compare to the Sep '25 revenue of ₹ 0.09 crore. This represent the decline of -44.44% The revenue of Swadha Nature Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Genomic Valley Biotech Ltd for the Dec '25 is ₹ 0.01 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the growth of 9.2233718E16% The ebitda of Swadha Nature Ltd for the Dec '25 is ₹ -0.01 crore as compare to the Sep '25 ebitda of ₹ -0.01 crore. This represent the decline of 0% The net profit of Genomic Valley Biotech Ltd changed from ₹ 0.13 crore to ₹ 0.01 crore over 7 quarters. This represents a CAGR of -76.91% The net profit of Swadha Nature Ltd changed from ₹ 0.01 crore to ₹ -0.01 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Genomic Valley Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Swadha Nature Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Genomic Valley Biotech Ltd

Incorporated in May 1994, Genomic Valley Biotech Limited is formed with the objective of conducting research in the field of Biotechnology (Plant & Animal) and also to undertake commercial production of Plant Tissue Cultured Plants of different species to feed the genetically improved plant market nationally as well as internationally.
The Company is extensively involved in commercial greenhouse / poly house cultivation of crops.
Presently, it is engaged in high-tech cultivation through environmental controlled Poly Houses,NFT & DFT etc,manufacturing of Tissue Cultured Improved variety of plants and organic farming using Bio-Fertilizer.
Also it is involved in commercial Horticulture activities with Aloe vera, Tomato, Bitter Gourd, Bottle Gourd, Brinjal, Broccoli, Cabbage, Capsicum, Carrot, Cauliflower, Cucumber, Green Chillies, Onion, Radish, Ridge/Sponge Gourd, Leafy Vegetables, Pumpkin, Banana, Guava, Papaya, and Strawberry.

About Swadha Nature Ltd

Swadha Nature Limited was formerly incorporated as M S Securities Limited on February 12, 1992.
The Company has changed their name from M S Securities Limited to Swadha Nature Limited on July 20, 2023.
The Company engaged in making investments in capital market instruments, mutual fund and corporate loan to Promoter Company. The Company was a pioneer manufacturer of natural color based on modern technology.
The monopoly that India once enjoyed in these commodities has been eroded over the year with the entry of other countries in the field.
While tobacco exports have been affected by anti-smoking campaigns, the exports of rice, fruits and vegetables have been assed to the basket of exports from India. The Company has changed their object from 'Diversified Commercial Services' to 'Agriculture Business' on October 18, 2022.

FAQs for the comparison of Genomic Valley Biotech Ltd and Swadha Nature Ltd

Which company has a larger market capitalization, Genomic Valley Biotech Ltd or Swadha Nature Ltd?

Market cap of Genomic Valley Biotech Ltd is 7 Cr while Market cap of Swadha Nature Ltd is 4 Cr

What are the key factors driving the stock performance of Genomic Valley Biotech Ltd and Swadha Nature Ltd?

The stock performance of Genomic Valley Biotech Ltd and Swadha Nature Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Genomic Valley Biotech Ltd and Swadha Nature Ltd?

As of March 12, 2026, the Genomic Valley Biotech Ltd stock price is INR ₹25.13. On the other hand, Swadha Nature Ltd stock price is INR ₹10.6.

How do dividend payouts of Genomic Valley Biotech Ltd and Swadha Nature Ltd compare?

To compare the dividend payouts of Genomic Valley Biotech Ltd and Swadha Nature Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.